{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:d65379c4-b327-49f4-aed1-679103b53fde","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-09T17:05:28.640689+00:00","published_at":"2026-10-09T04:46:06.292481+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:1a2c1tm1grdvqi","event_type":"DIRECTOR_APPOINTED","effective_at":"2022-01-01","detected_at":"2026-10-09T04:46:06.292481+00:00","subject_ids":["alpha:person:catherine-moukheibir","alpha:company:d65379c4-b327-49f4-aed1-679103b53fde"],"caused_claim_ids":["alpha:claim:company:d65379c4-b327-49f4-aed1-679103b53fde:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:fead8b5d552bb13395d2835daba1486418d08b10d0446df9a6e165a133ac0d4a"],"summary":"Catherine Moukheibir seat on MoonLake Immunotherapeutics, effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:17nsf4js4646h","event_type":"DIRECTOR_APPOINTED","effective_at":"2022-01-01","detected_at":"2026-10-09T04:46:06.292481+00:00","subject_ids":["alpha:person:spike-loy","alpha:company:d65379c4-b327-49f4-aed1-679103b53fde"],"caused_claim_ids":["alpha:claim:company:d65379c4-b327-49f4-aed1-679103b53fde:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:fead8b5d552bb13395d2835daba1486418d08b10d0446df9a6e165a133ac0d4a"],"summary":"Spike Loy seat on MoonLake Immunotherapeutics, effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:15g7ut4171jml2","event_type":"COMMITTEE_CREATED","effective_at":"2022-01-01","detected_at":"2026-10-09T04:46:06.292481+00:00","subject_ids":["alpha:committee:moonlake-immunotherapeutics:audit-chair-compensation","alpha:company:d65379c4-b327-49f4-aed1-679103b53fde"],"caused_claim_ids":["alpha:claim:company:d65379c4-b327-49f4-aed1-679103b53fde:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:fead8b5d552bb13395d2835daba1486418d08b10d0446df9a6e165a133ac0d4a"],"summary":"Audit · Chair; Compensation committee of MoonLake Immunotherapeutics, effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:finejlxr1x4n","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2022-01-01","detected_at":"2026-10-09T04:46:06.292481+00:00","subject_ids":["alpha:person:catherine-moukheibir","alpha:committee:moonlake-immunotherapeutics:audit-chair-compensation"],"caused_claim_ids":["alpha:claim:company:d65379c4-b327-49f4-aed1-679103b53fde:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:fead8b5d552bb13395d2835daba1486418d08b10d0446df9a6e165a133ac0d4a"],"summary":"Catherine Moukheibir member of Audit · Chair; Compensation, effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1bspnfzc4jnw9","event_type":"COMMITTEE_CREATED","effective_at":"2022-01-01","detected_at":"2026-10-09T04:46:06.292481+00:00","subject_ids":["alpha:committee:moonlake-immunotherapeutics:audit-compensation","alpha:company:d65379c4-b327-49f4-aed1-679103b53fde"],"caused_claim_ids":["alpha:claim:company:d65379c4-b327-49f4-aed1-679103b53fde:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:fead8b5d552bb13395d2835daba1486418d08b10d0446df9a6e165a133ac0d4a"],"summary":"Audit; Compensation committee of MoonLake Immunotherapeutics, effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:194trs21dopho","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2022-01-01","detected_at":"2026-10-09T04:46:06.292481+00:00","subject_ids":["alpha:person:spike-loy","alpha:committee:moonlake-immunotherapeutics:audit-compensation"],"caused_claim_ids":["alpha:claim:company:d65379c4-b327-49f4-aed1-679103b53fde:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:fead8b5d552bb13395d2835daba1486418d08b10d0446df9a6e165a133ac0d4a"],"summary":"Spike Loy member of Audit; Compensation, effective 2022-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:d65379c4-b327-49f4-aed1-679103b53fde:leadership_role:7","subject_id":"alpha:company:d65379c4-b327-49f4-aed1-679103b53fde","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:catherine-moukheibir","object_label":"Catherine Moukheibir","object_source_name_forms":[],"value":"Catherine Moukheibir: Director, Audit · Chair; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:catherine-moukheibir","name":"Catherine Moukheibir"},"title":"Director","role_category":"director","committee":"Audit · Chair; Compensation","is_board_chair":false,"is_independent":true,"start_date":"2022-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-09T04:46:06.292481+00:00","sources":[{"id":"alpha:projection-evidence:document:fead8b5d552bb13395d2835daba1486418d08b10d0446df9a6e165a133ac0d4a","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"MoonLake Immunotherapeutics DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1821586/000114036126015916/ny20067252x1_def14a.htm","source_date":"2026-04-21","retrieved_at":"2026-04-24T23:32:01.206+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-09T04:46:06.292481+00:00","reviewed_at":"2026-10-09T04:46:06.292481+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d65379c4-b327-49f4-aed1-679103b53fde:leadership_role:8","subject_id":"alpha:company:d65379c4-b327-49f4-aed1-679103b53fde","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:spike-loy","object_label":"Spike Loy","object_source_name_forms":[],"value":"Spike Loy: Director, Audit; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:spike-loy","name":"Spike Loy"},"title":"Director","role_category":"director","committee":"Audit; Compensation","is_board_chair":false,"is_independent":true,"start_date":"2022-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-09T04:46:06.292481+00:00","sources":[{"id":"alpha:projection-evidence:document:fead8b5d552bb13395d2835daba1486418d08b10d0446df9a6e165a133ac0d4a","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"MoonLake Immunotherapeutics DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1821586/000114036126015916/ny20067252x1_def14a.htm","source_date":"2026-04-21","retrieved_at":"2026-04-24T23:32:01.206+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-09T04:46:06.292481+00:00","reviewed_at":"2026-10-09T04:46:06.292481+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:fead8b5d552bb13395d2835daba1486418d08b10d0446df9a6e165a133ac0d4a","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"MoonLake Immunotherapeutics DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1821586/000114036126015916/ny20067252x1_def14a.htm","source_date":"2026-04-21","retrieved_at":"2026-04-24T23:32:01.206+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.801,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.756,"cross_source_agreement":0.75,"temporal_completeness":0.25},"diagnostics":{"published_claims":16,"factual_claims":16,"claims_with_linked_evidence":16,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":8,"temporal_claims_with_valid_from":2,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","executive_role","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-09T04:46:06.292481+00:00","observed_at":"2026-10-09T04:46:06.292481+00:00","reviewed_at":"2026-10-09T04:46:06.292481+00:00","verified_at":"2026-10-09T04:46:06.292481+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":16,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/moonlake-immunotherapeutics/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/moonlake-immunotherapeutics?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}